Atypical Nevi When to Re-excise. Catherine Barry, DO Dermatopathologist

Similar documents
LENTIGO SIMPLEX. Epidemiology

Diagnoses of Cases 1. Lentigo, other melanosis and the acquired nevus 2. Variations on the acquired nevus 3. Dermal melanocytosis

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

Dermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.

Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more

IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY

Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc

Malignant tumors of melanocytes: Part 1. Deba P Sarma, MD., Omaha

Pathology of the skin. 2nd Department of Pathology, Semmelweis University

Identifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018

Dermatopathology. Dr. Rafael Botella Estrada. Hospital La Fe de Valencia

Associate Clinical Professor of Dermatology MUSC

Index. Springer-Verlag Berlin Heidelberg 2017 J.A. Plaza, V.G. Prieto, Pathology of Pigmented Skin Lesions, DOI /

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 12, :30 am 11:00 am

Cutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D.

Clinical characteristics

المركب النموذج--- سبيتز وحمة = Type Spitz's Nevus, Compound SPITZ NEVUS 1 / 7

Common Benign Lesions and Skin Cancers. 22nd May 2015 Dr Mark Foley

Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial

Histopathology: skin pathology

Melanocytic Lesions: Use of Immunohistochemistry and Special Studies Napa Valley 2018

Melanoma: The Basics. What is a melanocyte?

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 13, :30 am 11:00 am

SKIN CANCER. Most common cancer diagnosis 40% of all cancers

Malignant Melanoma Early Stage. A guide for patients

Histopathology of Melanoma

Skin Cancer. 5 Warning Signs. American Osteopathic College of Occupational and Preventive Medicine OMED 2012, San Diego, Monday, October 8, 2012 C-1

Guy Perrot (Ги Перро)

David B. Troxel, MD. Common Medicolegal Situations: Misdiagnosis of Melanoma

Learning Objectives. Tanning. The Skin. Classic Features. Sun Reactive Skin Type Classification. Skin Cancers: Preventing, Screening and Treating

Sun Safety and Skin Cancer Prevention. Maryland Skin Cancer Prevention Program


MELANOMA. Some people are more likely to get a m Melanoma than others:

Simulators of melanoma

Periocular Malignancies

Pathology. Skin Tumor. Bayan N. Mohammad 15/10/2015. Mohammad al-orjani. Page 0 of 23

PATHOLOGY OF THE SKIN 2. Tumours of the skin

MELANOMA. 4 Fitzroy Square, London W1T 5HQ Tel: Fax: Registered Charity No.

Living Beyond Cancer Skin Cancer Detection and Prevention

An Overview of Melanoma. Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center

Cancer Reporting for Dermatologists. Florida Department of Health Florida Cancer Data System. March 9, Agenda

Conflict of Interest 9/2/2014. Pathogenesis and Comparison of Atypical Spitz Nevi vs Benign Spitz, and Childhood Melanoma

1. Opdivo + Ipilumimab is now the first line therapy for metastatic melanoma.

Dermoscopy: Recognizing Top Five Common In- Office Diagnoses

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated

Actinic keratosis (AK): Dr Sarma s simple guide

Financial disclosures

VACAVILLE DERMATOLOGY

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL

Basal cell carcinoma 5/28/2011

BAP-oma & BEYOND MICHAEL A NOWAK, MD

Toby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma

أملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5

Toby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma

SKIN. 3. How is the skin structured around the finger joints to allow for flexible movement of the fingers?

Multiple Primary Melanoma in a Thai Male: A Case Report

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated

Identifying Benign and Malignant Skin Lesions. No Disclosures. Common Benign Lesions. Benign Lesions 2/25/2018. Stucco Keratoses.

Malignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha

Case Report Clear Cell Basal Cell Carcinoma

LUMPS AND BUMPS: AN ORGANIZED APPROACH TO DIAGNOSIS AND MANAGEMENT

Metastatic Melanoma. Cynthia Kwong February 16, 2017 SUNY Downstate Medical Center Department of Surgery Grand Rounds

Talking to Your Clients About Skin Cancer. Objectives 9/9/2017. Amanda Friedrichs, MD, FAAD AMTA National Conference September 14, 2017

Glenn D. Goldman, MD. University of Vermont Medical Center. University of Vermont College of Medicine

Melanoma. Kaushik Mukherjee MD A. Scott Pearson MD

1/10/2018. Soft Tissue Tumors Showing Melanocytic Differentiation. Overview. Desmoplastic/ Spindle Cell Melanoma

Oral and Maxillofacial Surgery Department

ARTICLE INFO ABSTRACT

Appendix : Dermoscopy

Dermatological Manifestations in the Elderly. Sanjay Siddha Staff Dermatologist UHN & MSH

Maligna Melanoma and Atypical Fibroxanthoma: An Unusual Collision Tumour G Türkcü 1, A Keleş 1, U Alabalık 1, D Uçmak 2, H Büyükbayram 1 ABSTRACT

Gross Appearance & Histology of Skin Cancer. Kyle Mannion M.D. January 21, 2005

Melanoma what is it? Most aggressive and lifethreatening

Lichenoid Tissue Reaction in Malignant Melanoma A Potential Diagnostic Pitfall

Pigmented lesions of the Oral cavity

Integumentary System

Regression 2/3/18. Histologically regression is characterized: melanosis fibrosis combination of both. Distribution: partial or focal!

Steven Robinson. Steven Robinson Memorial Endowment at

Skin Cancers Emerging Trends and Treatment Approaches

Brief Report. Shivanand Gundalli 1, Smita Kadadavar 1, Somil Singhania 1, Rutuja Kolekar 2 INTRODUCTION. Melanocytic Nevus

EXCESSIVE SUN EXPOSURE A DANGER FACTOR FOR THE SKIN

Epidemiology. Objectives 8/28/2017

Skin Cancer Awareness

Melanoma Update: 8th Edition of AJCC Staging System

Update on Spitzoid and Blue nevus-like melanocytic lesions Emphasis on molecular studies informing diagnosis, prognosis and therapy

Management of pediatric melanocytic lesions

Springer Healthcare. Staging and Diagnosing Cutaneous Melanoma. Concise Reference. Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone

EARLY ONLINE RELEASE

Glenn D. Goldman, MD. Fletcher Allen Health Care. University of Vermont College of Medicine

Skin Malignancies. Presented by Dr. Douglas Paauw

Associate Professor Amanda Oakley. Professor H. Peter Soyer. Academic Dermatologist The University of Queensland Brisbane. Dermatologist Hamilton

Cutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma. Cutaneous Melanoma: Epidemiology (USA)

Disclosures. I have no conflicts of interest to disclose

CH 05 THE INTEGUMENTARY SYSTEM

F006 Imaging in Dermatology Melanocytic Neoplasia Clinical-Confocal-Pathological-Correlations

MELANOMA IN ADOLESCENTS AND YOUNG ADULTS

Large majority caused by sun exposure Often sun exposure before age 20 Persons who burn easily and tan poorly are at greatest risk.

Transcription:

Atypical Nevi When to Re-excise Catherine Barry, DO Dermatopathologist

Why talk about skin cancer? Because it s the most common type of cancer!

Non-melanoma Skin Cancers Basal Cell Carcinoma Squamous Cell Carcinoma Leiomyosarcoma Dermatofibrosarcoma Protuberans Sebaceous Carcinoma Merkel Cell Carcinoma Microcystic Adnexal Carcinoma There are even more than these!

Non Melanoma Skin Cancer > 1,300,000 per year 20% lifetime risk in fair-skinned individuals Incidence rising Increased leisure time? Increased UV radiation? Increased awareness?

Most Common Skin Cancers Basal Cell Carcinoma 1 million/year Squamous Cell Carcinoma 250,000/year Malignant Melanoma 50,000/year

Cells of Origin Basal keratinocyte Keratinocyte Melanocyte

Skin Cancer Deaths 10,000 deaths/year in U.S. 7,000 from Melanoma

Etiology Ultraviolet Light induced mutations BCC PTCH gene mutations p53 mutations SCC P53 mutations Melanoma Less clear

Introduction Melanocytes Overview of benign nevi Selected benign pigmented lesions Aypical Melanocytic Lesions /Melanoma precursors Malignant melanoma

Overview Selected benign pigmented lesions Freckle (ephelides) Labial melanotic macule Solar lentigo Lentigo simplex Lentiginous junctional melanocytic nevus Lentiginous compound melanocytic nevus Aypical Melanocytic Lesions /Melanoma precursors Dysplastic nevi / Clark s nevus / B-K mole Mild Moderate Severe Margins Treatment and re-exision Malignant melanoma Margins Re-excision

The Melanocyte

Normal Melanocytes Melan-A (Mart-1) Dispersed within the basal layer approximately one melanocyte per 10 keratinocytes Varies with location Highest face and male genitailia Lowest trunk

Melanocytes Overview Melan-A highly branched connected to approximately 36 keratinocytes through dendritic processes The number of melanocytes is the same between all races In African Americans the melanocytes are larger and contain more highly dendritic melanocytes The color of your skin is determined by the number of melanosomes contained within the melanocytes The number of melanosomes is greater in the basal layer and they get degraded within the keratinocytes as they move upwards and are shed

With exposure to UV light melanocytes increase in size and functional activity but not in number Specialized organelles of the melanocytes called melanosomes. Melanosomes develop in four stages and move from the cytoplasm to the dendritic processes Receptors on keratinocytes is a key receptor involved in the melanosome transfer These are transferred to the keratinocytes by a receptor on the keratinocyte (proteaseactivated receptor 2, PAR-2) Pinocytotic process where they fuse with acid lysosomes. With time the keratinocytes and melanocytes migrate to the surface of the skin and are shed

Melanin granules (Warthin-Starry Stain) Melanin gets impregnanted by silver nitrate solutions. When reduced to silver it turns black

Increased Melanin in Keratinocytes Freckle (ephelides) Labial melanotic macule Lentigo simplex Solar lentigo

Freckle (ephelides)

Labial and Genital Melanotic Macules

Lentigo Simplex (Simple Lentigo) Variable basal hyperpigmentation Increased number of single melanocytes in the basal layer Elongation of rete ridges

Multiple Lentigines Xeroderma pigmentosum Peutz-Jeghers Laugier-Hunziker Myxoma Syndromes LAMB NAME Carney LEOPARD Syndrome

Solar (Senile) Lentigo

Clinical Occurs after exposure to psoralens (methoxsalen) and ultraviolet-a radiation (PUVA) Especially in sun protected areas PUVA Lentigo

Increased Melanin in Keratinocytes and nests of melanocytes Lentiginous nevus Lentiginous junctional melanocytic nevus Lentiginous compound melanocytic nevus Nevus spilius

Lentiginous Nevus

Speckled Lentiginous Nevus Present at birth or appear in childhood Considered a variant of congenital nevus (Nevus Spilus)

Immunohistochemistry S100 stains dermal melanocytes that other stains may not, also stains Langerhan s cells Mel-A (Mart-1) HMB45 Tyrosinase MITF - Microphthalmia Transcription Factor NKI/C-3 Melan-A

Melanocytic Nevi Junctional Nevus Compound Nevus Most common Intradermal Nevus Meyerson s Nevus Ancient Nevus Deep Penetrating Nevus Balloon Cell Nevus Halo Nevus Cockarde Nevus Eccrine Centered Nevus Recurrent Nevus Spitz Nevus (Spindled and Epitheliod Cell Nevus) Pigmented Spindled Cell Nevus Congenital Nevus

Benign Proliferation of Melanocytes= Nevus Compound nevus Junctional nevus Intradermal nevus

Junctional Nevus Clinical Well circumscribed, brown black macule, develops anywhere on the body surface Usually appears during childhood or adolescence Skin lines are preserved

Compound Nevus Clinical Most common in children and adolescents Dome shaped to polypoid and may be tan or dark brown

Intradermal Nevus Clinical most common type of nevi, the majority are found in adults Dome shaped, nodular or polypoid, pink or slightly pigmented Coarse hairs may protrude from the surface

Other Dermal Melanocytic Lesions Mongolian Spot Nevus of Ota and Nevus of Ito Blue Nevus Cellular Blue Nevus Blue Nevus-like Metastatic Melanoma Malignant Blue Nevus Dermal Melanocytic Hamartoma Phakomatosis Pigmentovascularis Cutaneous Neurocristic Hamartoma

Aypical Melanocytic Lesions Melanoma precursors Dysplastic nevi / Clark s nevus / B-K mole Margins Treatment and re-exision

Correct terminology Dated termonology Dysplastic nevi originally described in 1978 by Wallace H. Clark Clark s nevus B-K mole Correct (Compound/Junctional) melanocytic nevus with architectural disorder and (mild/moderate/severe) atypia

Atypical Nevus 10% of melanocytic lesions received by pathology Dysplastic nevus syndrome In 1820 Norris reported the first case of what was originally called BK mole syndrome is now recognized as familial atypical mole/malignant melanoma syndrome (FAMM) syndrome Lifetime risk for melanoma 10% Familial or sporadic occurrence of multiple dysplastic (atypical) nevi in an individual May have up to 80 or more nevi that appear normal in childhood

ABCDE s Not all of these criteria need to be met Some melanomas only have one strike against them! A= Asymmetry B= Border C= Color D= Diameter > 6mm E= Evolution our newest and perhaps most important criteria!

E= Evolution My mole is changing My mole is growing My mole is itching This is a new mole

Atypical Nevus Clinical Larger than ordinary nevi Mixture of colors Pebbly surface

Atypical Nevus Junctional and compound melanocytic nevi can be atypical Histologically there are two components Architectural disorder Cytological atypia Mild Moderate re-excise if margin involved Severe re-excise if margin involved

Atypical Nevus Architectural Disorder Poorly circumscribed Broad extension

Atypical Nevus Architectural Disorder Shouldering junctional nests of melanocytes extending beyond the dermal component Bridging of the rete ridges

Single and nested melanocytes along the sides and tips of the rete ridges Chronic inflammation Fibroplasia Pigment incontinence

Atypical Nevus Cytological Atypia Mild Nucleus approximates size of keratinocyte nucleus Fine dusty cytoplasm Hyperchromatic nucleus, with mild pleomorphism Absent nucleolus Moderate re-excise 1-2x keratinocyte nucleus Fine dusty cytoplasm Hyperchromatic nucleus, with moderate pleomorphism Absent nucleus Severe re-excise 2x or greater keratinocyte nucleus Fine dusty cytoplasm Vesicular nucleus, with severe pleomorphism Prominent nucleolus Abundant cytoplasm

Atypical Nevus 1. Architectural disorder Shouldering proliferation of junctional nests of melanocytes extending beyond the dermal component Intraepidermal lentiginous hyperplasia of melanocytes Proliferation of melanocytes singly and in nests along the basal layer (sides and tips of rete ridges) 2. Cytological atypia Large hyperchromatic cells with prominent nucleoli (nuclei equal or larger than the nucleus of the overlying keratinocytes) Spindled Large epitheliod Stromal response Concentric lamellar fibroplasia Proliferation of dermal dendrocytes Patchy lymphocytic infiltrate Small vessel proliferation

Bottom line SAMPLE PATHOLOGY REPORT SKIN, RIGHT ARM, SHAVE BIOPSY: Compound melanocytic nevus with architectural disorder and mild cytological atypia Margins involved No re-excision necessary Close clinical follow up. If the lesion returns in 6 months re-excision may be necessary

Bottom line SAMPLE PATHOLOGY REPORT SKIN, RIGHT ARM, SHAVE BIOPSY: Compound melanocytic nevus with architectural disorder and moderate/severe cytological atypia Margins involved RE-EXCISE 2-5mm clinical margins

Malignant proliferation of melanocytes= Melanoma

Melanoma 1 in 80 Americans Incidence increased 1000% in past 50 years Risks Light complexions Light eyes Blond or red hair Blistering sunburns Heavy freckling Tanning poorly

Melanoma Most often begin from melanocytes at dermal-epidermal junction About half evolve from pre-existing nevi Horizontal and vertical growth phase Survival nearly ensured if lesion caught early!

Confined to the epidermis Often found on face of elderly patients with sun damage Melanoma caught early has the best prognosis Melanoma in situ

Melanoma in situ= confined to the epidermis

Melanoma in situ Bottm line Re-excision with 5mm clincial margins

Invasive Melanoma Melanoma which has grown into the dermis This happens quickly in some patients but slowly in others Prognosis based on depth of invasion and presence of ulceration Sentinel node biopsy is a newer prognostic test

Invasive Melanoma Biopsy Critical Need to sample the entire lesion if possible Often requires excision either with sutures or deep shave If excision is not possible, do an incisional biopsy But tell your pathologist you are sending a piece of a very large lesion!

How to biopsy this lesion? Remove entire lesion with a margin, deep to fat

Amelanotic melanoma- difficult to diagnose

Acral lentiginous melanoma Most common type of melanoma in darker skinned patients Which famous singer died of this?

Invasive melanoma Breslow Depth <1mm Re-excision with 1cm clincal margins results in 90% survival

ABCDE s of Melanoma Not all of these criteria need to be met Some melanomas only have one strike against them! A= Asymmetry B= Border C= Color D= Diameter > 6mm E= Evolution our newest and perhaps most important criteria!

E= Evolution My mole is changing My mole is growing My mole is itching This is a new mole

Primary Melanoma: What factors influence prognosis? Depth of invasion is the single most important factor in survival --ulceration is next

Excision and FNA of Left Groin Mass

BRAF V600E mutation BRAF is a proto-oncogene. Mutations result in activation of signaling pathways that lead to uncontrolled cell growth and oncogenesis Roughly 50% of melanomas carry one of these mutations, most commonly a single amino acid change at position 600, V600E.

Treatment Surgical metastasectomy Immunotherapy High dose IL-2 Ipilimumab Monoclonal antibodies against programmed death 1 protein (PD-1) and its ligand (PD1-L1) MAPK pathway inhibition for BRAF positive patients Vemurafenib Dahrafenib Radiation Chemotherapy

Treatment

Melanoma Survival

Melanoma Prevention Wear broad-spectrum sunblock! UVA and UVB blockers like titanium dioxide, zinc oxide, and mexoryl- and REAPPLY! Avoid mid-day sun exposure